Zobrazeno 1 - 10
of 44
pro vyhledávání: '"Daisuke Miyaki"'
Autor:
Hiroshi Kohno, Kei Morio, Akira Hiramatsu, Yoshiiku Kawakami, Keiji Tsuji, Hiroshi Aikata, Hideyuki Hyogo, Masahiro Hatooka, Hirotaka Kohno, Daisuke Miyaki, Koji Waki, Reona Morio, Tomoki Kobayashi, Shoichi Takahashi, Noriaki Naeshiro, Kazuaki Chayama, Tomokazu Kawaoka, Michio Imamura, Takayuki Fukuhara, Takashi Moriya
Publikováno v:
Journal of Digestive Diseases. 16:505-512
Objectives Sorafenib is the standard treatment for advanced hepatocellular carcinoma (HCC) with distant metastasis, unresectable HCC, and those refractory to transcatheter arterial chemoembolization (TACE) or with macroscopic vascular invasion (MVI).
Autor:
Takuji Yamagami, Michio Imamura, Takayuki Fukuhara, Kazuaki Chayama, Tomokazu Kawaoka, Tomoki Kobayashi, Hiromi Kan, Rika Yoshimatsu, Hideyuki Hyogo, Masataka Tsuge, Noriaki Naeshiro, Daisuke Miyaki, Yohji Honda, Yoshiiku Kawakami, Hatsue Fujino, Akira Hiramatsu, Hiroshi Aikata, Kazuo Awai
Publikováno v:
Journal of Gastroenterology and Hepatology. 30:726-732
Background and Aim To assess the early response and outcome of hepatic arterial infusion chemotherapy (HAIC) in patients with advanced hepatocellular carcinoma (HCC). Methods One hundred sixty-five HCC patients treated with HAIC were reviewed retrosp
Autor:
Hatsue Fujino, Eisuke Murakami, Masataka Tsuge, Hidenori Ochi, Yohji Honda, Hiroshi Aikata, Hideyuki Hyogo, Tomoki Kobayashi, Atsushi Ohno, Noriaki Naeshiro, Hiromi Kan, Michio Imamura, Takayuki Fukuhara, Akira Hiramatsu, Takashi Nakahara, Kazuaki Chayama, Tomokazu Kawaoka, Daisuke Miyaki, Yoshiiku Kawakami, Nobuhiko Hiraga
Publikováno v:
Hepatology Research. 45:656-662
Aim To assess the efficacy and safety of the anticoagulant drug, danaparoid sodium, in the treatment of portal vein thrombosis (PVT) in patients with liver cirrhosis. Methods A consecutive 26 cirrhotic patients with PVT were enrolled in this retrospe
Autor:
Hatsue Fujino, Yohji Honda, Takuji Yamagami, Hiroshi Aikata, Tomoki Kimura, Yoshiiku Kawakami, Masahiro Kenjo, Hiromi Kan, Kazuo Awai, Masataka Tsuge, Rika Yoshimatsu, Shoichi Takahashi, Kazuaki Chayama, Yasushi Nagata, Tomokazu Kawaoka, Hideyuki Hyogo, Tomoki Kobayashi, Daisuke Miyaki, Akira Hiramatsu, Noriaki Naeshiro, Michio Imamura, Takayuki Fukuhara
Publikováno v:
Hepatology Research. 45:607-617
Aim To evaluate the response, survival and safety on 3-D conformal radiotherapy (3D-CRT) for major portal vein tumor thrombosis (PVTT) combined with hepatic arterial infusion chemotherapy (HAIC) for advanced hepatocellular carcinoma (HCC). Methods In
Autor:
C. Nelson Hayes, Michio Imamura, Noriaki Naeshiro, Atsushi Ono, Takayuki Fukuhara, Akira Hiramatsu, Daisuke Miyaki, Hatsue Fujino, Hiroshi Aikata, Ayako Urabe, Yoshiiku Kawakami, Masataka Tsuge, Tomoki Kobayashi, Yuko Nagaoki, Hiromi Kan, Satoe Yokoyama, Kazuaki Chayama, Tomokazu Kawaoka, Hidenori Ochi, Shoichi Takahashi, Eisuke Murakami, Takashi Nakahara
Publikováno v:
Hepatology Research. 44:E447-E454
Aim The predictive value of the recently identified interferon-λ (IFNL)4 polymorphism on the outcome of telaprevir (TVR), pegylated interferon (PEG IFN) plus ribavirin (RBV) combination therapy for chronic hepatitis C is unknown. Methods We assessed
Autor:
Michio Imamura, Takayuki Fukuhara, Kazuaki Chayama, Akira Hiramatsu, Hiromi Kan, Tomokazu Kawaoka, Noriaki Naeshiro, Tomoki Kobayashi, Hatsue Fujino, Hideyuki Hyogo, Hiroshi Aikata, Yoshiiku Kawakami, Daisuke Miyaki
Publikováno v:
Hepatology Research. 44:1320-1328
Aim The purpose of this study was to assess the clinical outcome and identify prognostic factors following treatment of patients with advanced hepatocellular carcinoma (HCC) and extrahepatic metastasis with sorafenib. Methods Sixty-one HCC patients w
Autor:
Hatsue Fujino, Masataka Tsuge, Akira Hiramatsu, Noriaki Naeshiro, Tomoki Kobayashi, Yohji Honda, Hideyuki Hyogo, Hiroshi Aikata, Michio Imamura, Kazuo Awai, Hideaki Kakizawa, Takayuki Fukuhara, Atsushi Ohno, Shoichi Takahashi, Kazuaki Chayama, Tomokazu Kawaoka, Hiromi Kan, Daisuke Miyaki, Yoshiiku Kawakami, Nobuhiko Hiraga
Publikováno v:
Journal of Gastroenterology and Hepatology. 29:1035-1042
Background and Aim To assess the short- and long-term outcome of patients with gastric varices (GV) after balloon-occluded retrograde transvenous obliteration (B-RTO) by comparing bleeding cases with prophylactic cases. Methods Consecutive 100 patien
Autor:
Hatsue Fujino, Masataka Tsuge, Noriaki Naeshiro, Hiromi Kan, Keiichi Masaki, Michio Imamura, Akira Hiramatsu, Takayuki Fukuhara, Atsushi Ohno, Hiroshi Aikata, Yoshiiku Kawakami, Takashi Nakahara, Eisuke Murakami, Yohji Honda, Hideyuki Hyogo, Shoichi Takahashi, Daisuke Miyaki, Kazuaki Chayama, Tomokazu Kawaoka, Tomoki Kobayashi
Publikováno v:
Kanzo. 55:604-611
Autor:
Hatsue, Fujino, Michio, Imamura, Yuko, Nagaoki, Yoshiiku, Kawakami, Hiromi, Abe, C Nelson, Hayes, Hiromi, Kan, Takayuki, Fukuhara, Tomoki, Kobayashi, Keiichi, Masaki, Atsushi, Ono, Takashi, Nakahara, Youji, Honda, Noriaki, Naeshiro, Ayako, Urabe, Satoe, Yokoyama, Daisuke, Miyaki, Eisuke, Murakami, Tomokazu, Kawaoka, Nobuhiko, Hiraga, Masataka, Tsuge, Akira, Hiramatsu, Hideyuki, Hyogo, Hiroshi, Aikata, Shoichi, Takahashi, Daiki, Miki, Hidenori, Ochi, Waka, Ohishi, Kazuaki, Chayama, Keitaro, Yamashina
Publikováno v:
Journal of Gastroenterology. 49:1548-1556
Older patients with chronic hepatitis C have a lower virological response to interferon (IFN) treatment compared to younger patients. The efficacy of telaprevir (TVR) and PEG-IFN plus ribavirin combination therapy and the predictive value of recently
Autor:
Noriaki Naeshiro, Yohji Honda, Masataka Tsuge, Hideaki Kakizawa, Hiromi Kan, Masaki Ishikawa, Hiroshi Aikata, Kazuo Awai, Hideyuki Hyogo, Michio Imamura, Akira Hiramatsu, Hatsue Fujino, Takayuki Fukuhara, Kazuaki Chayama, Tomokazu Kawaoka, Tomoki Kobayashi, Yoshiiku Kawakami, Daisuke Miyaki
Publikováno v:
Hepatology Research. 44:740-749
Aim To evaluate the clinical outcomes of percutaneous transvenous embolization (PTE) for portosystemic shunt (PSS) associated with encephalopathy Methods Fourteen patients with portosystemic encephalopathy (PSE) were enrolled in this retrospective co